Teva Pharmaceutical Industries Limited (NYSE: TEVA) is a large market cap stock with a market cap of 51301.7. It is in the Drug Manufacturers – Other industry and sector Healthcare, with a current P/E of 26.01, a forward P/E of 8.39 and EPS of 1.92. At a stock price of 49.97 (-0.16%) it has a dividend yield of 2.72%.
EPS growth for the last five years have been -13.10%, more recently this last year it has grown by -48.90%. The next year growth is going to be about 13.58% and more long-term 5.22% after five years. EPS growth quarter over quarter is 19.10%. Sales growth for the past five years have been 4.00% and sales growth quarter over quarter is -3.50%.
For performance, Teva Pharmaceutical Industries Limited the past week has seen a gain of 2.97%. For the last month performance for Teva Pharmaceutical Industries Limited is -7.10%. While the last quarter is -7.78% and half year, -22.50%. Finally for the year, performance is -17.04%.
The 52-week high for Teva Pharmaceutical Industries Limited, is at -29.26%, and for the 52-week low it comes to a value of 4.08%. The 20-day simple moving average is -4.43% and -12.90% for the 200-day simple moving average.
Volatility for the week is at 1.42%, and for the month it is 2.01%. Teva Pharmaceutical Industries Limited, has a target price of 71.68.
In terms of debt, long term debt/equity is 0.28, and for total debt/equity Teva Pharmaceutical Industries Limited has 0.34. The gross margin is 58.10%, while operating margin is 19.30%, the profit margin is 8.70%. The current ratio is 1.3 and the quick ratio is 1.
Insider ownership is at 2.70%, with instituitional ownership at 60.00%. Teva Pharmaceutical Industries Limited has a payout ratio of 70.10%. With the total shares outstanding coming to 1026.65. The shares float is 1022.25, with the float short at 2.36%, with short ratio coming to 4.
In terms of returns, the return on assets see Teva Pharmaceutical Industries Limited, get 3.30%, with its returns on investment at 5.70%. Return on equity is 6.60%. So will the investors see the target price of 71.68, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.